CVRx, Inc.
Clinical trials sponsored by CVRx, Inc., explained in plain language.
A medical device company developing neuromodulation therapies for cardiovascular diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- A neck implant aims to quiet Hard-to-Treat high blood pressure Results expected Jul 2027 (estimated)
- Nerve-stimulating implant tested for easing heart failure symptoms Results expected Jul 2027 (estimated)
-
Neck implant aims to tame stubborn high blood pressure
Disease control CompletedResearchers are studying the long-term safety and effectiveness of the Barostim Neo System in people with uncontrolled high blood pressure who already received the implant. Participants continue their usual blood pressure medications while the device stimulates nerves in the neck…
Sponsor: CVRx, Inc. • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Could a Pacemaker-Like device ease heart failure?
Disease control CompletedThis trial tested a device called Barostim neo that stimulates nerves to help control blood pressure in people with advanced heart failure. Over 1,000 participants received either the device or standard medical care. The goal was to see if the device could reduce heart-related de…
Sponsor: CVRx, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Implanted device aims to ease heart failure symptoms
Symptom relief CompletedResearchers are studying whether the Barostim NEO device, which stimulates a nerve near the carotid artery to lower blood pressure, can help people with heart failure and preserved ejection fraction. The registry follows 11 people who already received the device for resistant hyp…
Sponsor: CVRx, Inc. • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC